CD31 Antibody Market size was valued at USD 1.2 Billion in 2024 and is projected to reach USD 2.5 Billion by 2033, exhibiting a CAGR of 9.5% from 2026 to 2033.
The Malaysia CD31 Antibody market has been witnessing substantial growth in recent years, largely driven by its diverse applications across various industries. CD31, also known as Platelet Endothelial Cell Adhesion Molecule (PECAM-1), is a crucial protein found on the surface of endothelial cells. This protein plays a pivotal role in cell-cell interactions, immune responses, and angiogenesis, making CD31 antibodies essential in biomedical and research applications. The demand for CD31 antibodies in Malaysia has increased significantly due to their critical role in vascular biology, cancer research, and diagnostics.
Industries such as biotechnology, pharmaceuticals, and medical research are among the major drivers for the growing requirement of CD31 antibodies. The primary use of these antibodies is in the study of angiogenesis, especially in cancer and cardiovascular diseases, where CD31 serves as a marker for endothelial cells. Additionally, the rise in the number of research institutions and growing government investments in healthcare and biotechnology research have contributed to the increased consumption of CD31 antibodies in the region.
One of the key factors influencing the Malaysia CD31 Antibody market is the growing trend of personalized medicine and immunotherapy. With advancements in targeted therapies, the need for precise biomarkers like CD31 has become crucial in the development of individualized treatments, particularly for cancer patients. Pharmaceutical companies are investing in CD31 antibody-based diagnostic tools to enhance the accuracy of clinical testing, making these antibodies a valuable asset in medical diagnostics.
Furthermore, the rise in awareness of cardiovascular diseases and the need for more effective treatments have spurred a surge in CD31 antibody utilization. CD31 antibodies are being used extensively to study endothelial cell function, a key element in understanding and treating cardiovascular conditions. This demand has also led to an increase in the availability of these antibodies, with various suppliers offering products tailored to specific research needs, further driving market expansion.
In conclusion, the Malaysia CD31 Antibody market is experiencing significant growth due to the increasing demand for precise biomarkers in clinical diagnostics and research. As the applications of CD31 antibodies expand in cancer, cardiovascular diseases, and personalized medicine, industries across biotechnology, pharmaceuticals, and medical research will continue to rely on these antibodies for breakthrough innovations and improved patient outcomes.
Get an In-Depth Research Analysis of the Malaysia CD31 Antibody Market Size And Forecast [2025-2032]
BosterBio
Bio-Rad
Bioss
Thermo Fisher Scientific
NSJ Bioreagents
R and D Systems
Abcam
BioLegend
GeneTex
Novus Biologicals
SouthernBiotech
LifeSpan BioSciences
Enzo Life Sciences
Bethyl Laboratories
Abbexa
ProSci
Proteintech
Synaptic Systems
BIOCARE MEDICAL
CUSABIO Technology
Absolute Antibody
EpiGentek
Biorbyt
Wuhan Fine Biotech
Sino Biological
By 2030, Malaysia is expected to witness significant momentum in the market research industry, aligning with the global projection of surpassing $120 billion, driven by a compound annual growth rate (CAGR) of over 5.8% from 2023 to 2030. The industry in Malaysia is being reshaped by technological disruptions, particularly through the adoption of machine learning, artificial intelligence, and advanced data analytics. These technologies provide businesses with predictive analysis and real-time consumer insights, enabling smarter and more precise decision-making. As part of the broader Asia-Pacific region, Malaysia is positioned to contribute substantially to the over 35% revenue growth expected from this region. Additionally, the adoption of innovative techniques such as mobile surveys, social listening, and online panels is rapidly gaining ground in Malaysia, emphasizing speed, precision, and customization, and driving a new era of data-driven strategies across industries.
Â
Get Discount On The Purchase of the Malaysia CD31 Antibody Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Malaysia CD31 Antibody Market
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Chimeric Antibodies
Basic Research
Translational Research
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
CROs (Contract Research Organizations)
Direct Sales
Online Sales
Third-party Distributors
Liquid Formulations
Lyophilized Powders
Ready-to-use Kits
1. Singapore
Relationship: Strong economic ties; major trading partner.
Highlights: Advanced financial and logistics hub; shares deep cross-border business and travel links with Malaysia.
2. Indonesia
Relationship: Largest ASEAN economy; close cultural and linguistic ties.
Highlights: Major market for Malaysian exports; shared initiatives in palm oil, labor, and regional security.
3. Thailand
Relationship: Land-border neighbor with active cross-border trade.
Highlights: Strong tourism, agricultural, and automotive collaboration.
4. Brunei
Relationship: Close diplomatic and energy-sector ties.
Highlights: Joint ventures in oil & gas; similar Malay cultural heritage.
5. Philippines
Relationship: Regional partner in ASEAN; maritime neighbor.
Highlights: Collaborations in education, labor migration, and disaster relief.
6. Vietnam
Relationship: Growing trade and investment partner.
Highlights: Rising manufacturing hub; strong demand for Malaysian technology and services.
7. Cambodia, Laos, and Myanmar
Relationship: Developing ASEAN members with growing economic ties to Malaysia.
Highlights: Opportunities in construction, retail, and financial services.
For More Information or Query, Visit @ Malaysia CD31 Antibody Market Research Analysis
1. Introduction of the Malaysia CD31 Antibody Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Malaysia CD31 Antibody Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Malaysia CD31 Antibody Market, By Type
6. Malaysia CD31 Antibody Market, By Application
7. Malaysia CD31 Antibody Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia
Vietnam
8. Malaysia CD31 Antibody Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/